Bernier Meghan L, Jacob Ariel I, Collaco Joseph M, McGrath-Morrow Sharon A, Romer Lewis H, Unegbu Chinwe C
1 Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
2 Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pulm Circ. 2018 Jan-Mar;8(1):2045893217738143. doi: 10.1177/2045893217738143. Epub 2017 Oct 3.
Prior limited research indicates that children with pulmonary hypertension (PH) have higher rates of adverse perioperative outcomes when undergoing non-cardiac procedures and cardiac catheterizations. We examined a single-center retrospective cohort of children with active or pharmacologically controlled PH who underwent cardiac catheterization or non-cardiac surgery during 2006-2014. Preoperative characteristics and perioperative courses were examined to determine relationships between the severity or etiology of PH, type of procedure, and occurrence of major and minor events. We identified 77 patients who underwent 148 procedures at a median age of six months. The most common PH etiologies were bronchopulmonary dysplasia (46.7%), congenital heart disease (29.9%), and congenital diaphragmatic hernia (14.3%). Cardiac catheterizations (39.2%), and abdominal (29.1%) and central venous access (8.9%) were the most common procedures. Major events included failed planned extubation (5.6%), postoperative cardiac arrest (4.7%), induction or intraoperative cardiac arrest (2%), and postoperative death (1.4%). Major events were more frequent in patients with severe baseline PH ( P = 0.006) and the incidence was associated with procedure type ( P = 0.05). Preoperative inhaled nitric oxide and prostacyclin analog therapies were associated with decreased incidence of minor events (odds ratio [OR] = 0.32, P = 0.046 and OR = 0.24, P = 0.008, respectively), but no change in the incidence of major events. PH etiology was not associated with events ( P = 0.24). Children with PH have increased risk of perioperative complications; cardiac arrest and death occur more frequently in patients with severe PH and those undergoing thoracic procedures. Risk may be modified by using preoperative pulmonary vasodilator therapy and lends itself to further prospective studies.
先前有限的研究表明,患有肺动脉高压(PH)的儿童在接受非心脏手术和心脏导管插入术时围手术期不良结局的发生率更高。我们研究了一个单中心回顾性队列,该队列中的儿童患有活动性或药物控制的PH,并在2006年至2014年期间接受了心脏导管插入术或非心脏手术。我们检查了术前特征和围手术期过程,以确定PH的严重程度或病因、手术类型与主要和次要事件发生之间的关系。我们确定了77例患者,他们在中位年龄为6个月时接受了148次手术。最常见的PH病因是支气管肺发育不良(46.7%)、先天性心脏病(29.9%)和先天性膈疝(14.3%)。心脏导管插入术(39.2%)、腹部手术(29.1%)和中心静脉通路手术(8.9%)是最常见的手术。主要事件包括计划拔管失败(5.6%)、术后心脏骤停(4.7%)、诱导期或术中心脏骤停(2%)和术后死亡(1.4%)。严重基线PH患者的主要事件更频繁(P = 0.006),且发生率与手术类型相关(P = 0.05)。术前吸入一氧化氮和前列环素类似物治疗与次要事件发生率降低相关(优势比[OR]分别为0.32,P = 0.046和OR = 0.24,P = 0.008),但主要事件发生率无变化。PH病因与事件无关(P = 0.24)。患有PH的儿童围手术期并发症风险增加;严重PH患者和接受胸科手术的患者心脏骤停和死亡更频繁发生。术前使用肺血管扩张剂治疗可能会降低风险,这值得进一步进行前瞻性研究。